Ingredient label guide
Fadogia Agrestis: Evidence, Extracts, and Label Guide
Fadogia Agrestis is marketed in testosterone, libido, and male performance formulas, but controlled evidence is limited to animal research. Rat studies of aqueous stem extract cannot establish a human benefit, dose, or cycling protocol. Check the botanical name, plant part, preparation, extract ratio, amount per full serving, and blend disclosure before judging the claim.
Also listed as: Fadogia agrestis, Vangueria agrestis, Fadogia stem, Fadogia stem extract, 10:1 Fadogia extract, black aphrodisiac, or bakin gagai.
Overview
A fast-growing supplement claim built on a small animal evidence base
Fadogia Agrestis is the older botanical name for Vangueria agrestis, an accepted species in the Rubiaceae family. Kew describes it as a subshrub or shrub native from western tropical Africa to South Sudan. Both botanical names can appear in commerce, so a label should be read for identity rather than rejected solely because it uses the newer name. 1
Modern products usually position Fadogia as a testosterone or libido ingredient. That story traces mainly to studies of an aqueous stem extract in male rats. Those experiments provide a research signal, not evidence that a retail capsule raises testosterone, improves training, or is safe for people. 2, 3
The botanical name is only the first identity check
A complete line should also identify the plant part and preparation. Stem powder, an aqueous stem extract, a generic extract, and a 10:1 extract are not automatically equivalent. The word Fadogia alone does not establish which material was used or how closely it resembles the material studied in animals.
Evidence and claims
Rat findings do not validate a human testosterone protocol
Testosterone support
A short study reported higher serum testosterone in male rats given an aqueous stem extract. It did not establish an effective human dose, a durable effect, or a benefit from commercial Fadogia products. 2
Libido and sexual function
Rat studies reported changes in sexual-behavior measures and in a paroxetine-induced dysfunction model. The newer study itself called for clinical trials. Neither study proves an effect in people. 2, 3
LH mimic claims
The frequently repeated claim that Fadogia “mimics LH” is not established by the cited studies. Observing a testosterone change in rats does not identify the same mechanism as luteinizing hormone or show that it occurs in humans. 2
Muscle, recovery, and performance
The animal studies cited on this page did not test strength, hypertrophy, training recovery, or athletic performance in people. Those front-label promises run beyond the available evidence. 2, 3
Forms and label names
Plant part, extraction, and ratio change what the milligrams describe
The commonly cited reproductive studies used an aqueous stem extract. A retail product labeled only “Fadogia Agrestis” does not reveal whether it contains stem, root, aerial parts, or a mixture. A generic 10:1 claim also does not show that the finished extract has the same chemical profile as the research material. 2, 4
Some labels declare saponins, alkaloids, flavonoids, or another broad chemical class. That can add manufacturing detail, but no clinically validated Fadogia marker currently turns a percentage into a proven human dose or outcome. “Standardized” should name the constituent and percentage rather than stand alone.
What common form lines establish
- Fadogia agrestis or Vangueria agrestis
- The botanical identity is named. The line still needs a plant part, preparation, and amount per full serving.
- Fadogia Agrestis stem extract
- The plant part and extract wording are visible. It is closer in description to the aqueous stem material used in rat research, but that does not make the retail extract clinically validated.
- Fadogia Agrestis extract 10:1
- The ratio describes the relationship between starting material and finished extract. It is not a measured active amount or proof of greater effect.
- Standardized Fadogia extract
- Useful detail requires a named constituent and percentage. Even a complete statement does not establish a clinically effective or safe human dose.
Read the label
Start with identity and disclosure, not the testosterone headline
Begin with the Supplement Facts panel. Confirm the full serving size, Fadogia amount, botanical name, plant part, and preparation. If a ratio or standardization statement appears, record it exactly. A product name such as “testosterone support” does not answer any of those questions.
Illustrative Fadogia label lines
These examples show how disclosure changes interpretation. They are not product or dosing recommendations.
- Fadogia agrestis stem extract, 300 mg
- The botanical, plant part, preparation, and amount per listed serving are visible. Extract concentration and composition remain unspecified.
- Fadogia agrestis stem extract 10:1, 300 mg
- The line adds an extract ratio. It does not state the amount of a validated active constituent or make 300 mg a proven human dose.
- Fadogia stem extract, standardized to 10% saponins, 300 mg
- The percentage adds declared composition context. It does not establish botanical authenticity, human efficacy, or long-term safety.
- Male performance blend, 1,500 mg: Fadogia, Tongkat Ali, Ashwagandha
- The blend total is disclosed, but the individual Fadogia amount, plant part, and preparation remain hidden unless listed separately.
A practical Fadogia label check
- Confirm the full serving size and Fadogia amount per serving.
- Look for Fadogia agrestis or Vangueria agrestis.
- Record the plant part, especially whether stem is disclosed.
- Separate powder, generic extract, ratio extract, and standardized extract.
- Check whether Fadogia has its own amount or is hidden in a blend.
- Look for accessible, batch-specific identity and contaminant testing rather than a vague “lab tested” badge.
For the broader method, read How to Read Supplement Labels.
Compare the whole stack
A hormone-support stack can multiply uncertainty without proving synergy
Fadogia commonly appears beside Tongkat Ali, Ashwagandha, boron, or zinc. Similar testosterone or vitality positioning does not mean these ingredients share a mechanism, evidence base, dose scale, or safety profile. The cited Fadogia studies do not validate a combined commercial stack.
Illustrative supplement stack
This example shows why product names do not reveal the full formula. It is not a recommended combination.
- Fadogia product
- Fadogia stem extract 10:1, 300 mg per listed serving
- Male vitality blend
- Tongkat Ali, Fadogia, and boron inside a 1,200 mg proprietary blend
- Daily mineral formula
- Zinc and boron with their own disclosed amounts
- What remains uncertain
- Fadogia appears in two products, but its amount and preparation are hidden in one. The repeated marketing theme does not establish a combined benefit or suitable total exposure.
Amounts and evidence gap
There is no established evidence-based human dose or cycling schedule
Retail labels commonly display a confident milligram number, but a familiar number is not a validated dose. The published animal studies used body-weight doses of a defined aqueous stem extract. Those values should not be copied onto a human label or converted into a personal protocol without clinical evidence. 2, 4
How to interpret the number on the label
- Extract mass
- Read the disclosed amount per full serving. Do not present 300 mg, 600 mg, or another retail amount as proven effective or safe.
- 10:1 ratio
- The ratio can describe source-material concentration. It does not identify a clinically validated active dose and should not be used as a simple potency multiplier.
- Declared standardization
- A named percentage adds composition detail. Without a validated human marker and clinical range, it does not create an evidence-based target.
- Proprietary blend
- The blend total is not the Fadogia amount. Ingredient order cannot reveal the hidden quantity or preparation.
Serving size and suggested use answer different questions. A label may disclose 300 mg per capsule while suggesting two servings per day. Record the amount per full listed serving first, then read the directions without assuming that they establish a safe daily intake.
Cycling schedules promoted online have not been validated as a way to prevent adverse effects. A break between cycles does not turn an untested human dose into a proven safe protocol.
Safety and marketing limits
The same animal literature used for marketing also contains safety signals
In a 28-day male-rat study, repeated aqueous stem-extract exposure was associated with changes in testicular function indices. Some measures recovered after the lowest tested dose, but that does not establish a safe human threshold or prove that cycling protects people. 4
A separate rat study reported biochemical findings consistent with compromised liver-cell and kidney-cell membrane integrity after repeated exposure. No deaths or organ swelling were observed in that experiment, which is why the result should be described accurately as an animal toxicity signal rather than a proven human diagnosis. 5
Identity is a real product-quality issue
A chemical-fingerprint study examined 17 dietary supplements claiming to contain Fadogia. The target phenolic compounds were not detected in five products. This does not prove that every failed sample contained no plant material, but it shows why a front-label name and extract ratio are not enough to confirm identity or consistency. 6
A useful quality document is batch-specific and states what was tested, which method was used, and what result was obtained. A generic “third-party tested” logo does not establish Fadogia identity, clinical benefit, or human safety by itself.
Regulatory status can differ by market
In a 2025 European Union consultation, a 10:1 Vangueria agrestis extract was considered a novel food because significant food use in the European Union before May 15, 1997 was not demonstrated. That decision concerns market status, not proof of efficacy or safety, and requirements can differ by jurisdiction. 7
NutriDetector approach
How NutriDetector reads Fadogia Agrestis labels
The analysis checks supported Fadogia Agrestis wording, the disclosed amount and unit, serving context, blend transparency, and the surrounding formula. Visible plant-part, extract-ratio, or standardization wording can add label context, but it does not create an evidence-based human dose or make the ingredient dose-scoreable.
The result is limited to the submitted label. It cannot laboratory-test botanical identity, plant part, actual extract ratio or constituent content, purity, contaminants, or batch consistency, establish a human testosterone or performance effect, clear medicine interactions, or decide personal suitability. Compare extracted details with the original Supplement Facts panel before using the interpretation.
Analyze the full formula
Check the Fadogia line before trusting the testosterone claim.
NutriDetector keeps the disclosed Fadogia amount, serving context, visible preparation details, and hidden blend totals separate so a confident testosterone claim is not treated as evidence about the ingredient or its dose.
Questions and boundaries
Fadogia Agrestis supplement FAQ
What is Fadogia Agrestis?
Fadogia Agrestis is the older botanical name for Vangueria agrestis, a shrub in the Rubiaceae family native from western tropical Africa to South Sudan. Supplements commonly market stem or generic extracts for testosterone, libido, or male performance, but those human benefits are not established.
Does Fadogia Agrestis raise testosterone in humans?
That has not been established. A short study reported higher serum testosterone in male rats given an aqueous stem extract. Rat findings cannot confirm a human benefit, effective dose, duration, or response to a retail supplement.
Does Fadogia Agrestis mimic luteinizing hormone?
The cited studies do not establish that mechanism. A testosterone change in rats is not proof that Fadogia acts like luteinizing hormone, raises LH in people, or produces the same downstream effect as a human hormone.
What does a 10:1 Fadogia extract mean?
The ratio describes the relationship between the starting plant material and finished extract. It does not identify a clinically validated active constituent, prove botanical identity, or make the labeled milligrams an evidence-based human dose.
Is stem extract the best Fadogia form?
The commonly cited rat studies used aqueous stem extract, so stem wording helps identify how closely a label describes that research material. It does not prove that a commercial stem extract works in people, matches the study extract, or is safer than another preparation.
What is an effective Fadogia Agrestis dose?
No evidence-based human dose has been established. Retail amounts such as 300 mg or 600 mg should not be treated as proven effective or safe, and body-weight doses from rat studies should not be copied into a human protocol.
Does cycling make Fadogia Agrestis safe?
No clinical trial has validated a cycling schedule as a safety measure. Taking periodic breaks does not resolve unknown human dosing, product-identity, long-term safety, or interaction questions.
Is a Fadogia and Tongkat Ali stack evidence based?
The combination is common in male-vitality marketing, but the cited Fadogia studies did not test a Fadogia and Tongkat Ali stack in humans. Two ingredients sharing a testosterone claim does not establish synergy, a suitable combined dose, or safety.
What does NutriDetector check on a Fadogia label?
NutriDetector reviews supported Fadogia Agrestis wording, the disclosed amount per listed serving, serving context, blend transparency, and the surrounding formula. Visible plant-part, extract-ratio, or standardization wording can add label context, but it does not establish a human dose, benefit, or safety threshold. Hidden individual amounts remain visible as uncertainty.
Scientific references and regulatory sources
- Royal Botanic Gardens, Kew. Vangueria agrestis (Schweinf. ex Hiern) Lantz. Plants of the World Online. Accessed August 13, 2026. Kew Science.
- Yakubu MT, Akanji MA, Oladiji AT. Aphrodisiac potentials of the aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem in male albino rats. Asian J Androl. 2005;7(4):399-404. PubMed.
- Ogunro OB, Yakubu MT. Fadogia agrestis Stem Extract Restores Selected Biomolecules of Erectile Dysfunction in the Testicular and Penile Tissues of Paroxetine-Treated Wistar Rats. Reprod Sci. 2023;30(2):690-700. PubMed.
- Yakubu MT, Akanji MA, Oladiji AT. Effects of oral administration of aqueous extract of Fadogia agrestis stem on some testicular function indices of male rats. J Ethnopharmacol. 2008;115(2):288-292. PubMed.
- Yakubu MT, Oladiji AT, Akanji MA. Mode of cellular toxicity of aqueous extract of Fadogia agrestis stem in male rat liver and kidney. Hum Exp Toxicol. 2009;28(8):469-478. PubMed.
- Avula B, Bae JY, Raman V, et al. Quantification of Phenolic Compounds from Fadogia agrestis and Dietary Supplements using UHPLC-PDA-MS. Planta Med. 2019;85(2):145-153. PubMed.
- European Commission. Consultation request for the determination of the novel food status of Vangueria agrestis (syn. Fadogia agrestis) 10:1 herb extract. June 25, 2025. European Commission.